The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

TICAM1  -  toll-like receptor adaptor molecule 1

Homo sapiens

Synonyms: IIAE6, MGC35334, MyD88-3, PRVTIRB, Proline-rich, vinculin and TIR domain-containing protein B, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of TICAM1

  • These molecular motifs are encountered during viral and bacterial infection, and the apoptosis that occurs when TRIF is engaged represents an important host defense to limit the spread of infection [1].
  • Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF [2].
  • Although systemic parasitemia was comparable, sequestration of parasite and hemozoin load in the brain blood vessels was significantly lower in MyD88-deficient mice compared with those in TRIF-deficient or WT mice [3].
 

High impact information on TICAM1

  • A critical component of the innate immune system, TLRs utilize leucine-rich-repeat motifs for ligand binding and a shared cytoplasmic domain to recruit the adaptors MyD88, TRIF, TIRAP, and/or TRAM for downstream signaling [4].
  • Little is known about how TRIF pathway-dependent gene expression is regulated [5].
  • SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production [5].
  • Activating functions have been assigned to four TIR adaptors: MyD88, Mal, TRIF and TRAM [6].
  • The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling [6].
 

Biological context of TICAM1

  • Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif [1].
  • Upon overexpression, TRIF was the sole TIR-adapter to potently engage mammalian cell death signaling pathways [1].
  • Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways [7].
  • In spite of the presence of a STAT1 (signal transduction and activators of transcription 1) motif at position -330, the addition of type I or type II interferon had no effect on TRIF activity [8].
  • Here, we discuss how Trif and type I IFN are involved in the optimization of APC-T cell interaction in response not only to viral but also bacterial stimuli [9].
 

Anatomical context of TICAM1

  • The addition of CyP together with LPS completely inhibited both MyD88- and TRIF-dependent pathways and suppressed the whole LPS-induced gene transcription program in human dendritic cells (DCs) [10].
  • The activation of GEFH1-RhoB through the TRIF-dependent pathway of LPS in DC might be a critical target for controlling the activation of CD4+ T cells [11].
  • Although dsRNA upregulated the expression of IFNbeta, LPS did not indicating that the TRIF-dependent branch of TLR4 signaling is inactive in astrocytes [12].
  • This is in contrast to macrophages, which respond to LPS via both Trif- and MyD88-dependent pathways [13].
  • We hypothesize that unlike antigen-presenting cells, vascular endothelial cells (ECs) lack the Trif protein TRAM and are therefore incapable of eliciting Trif-dependent immune responses to LPS [13].
 

Associations of TICAM1 with chemical compounds

  • In LPS-mediated TLR4 activation, a complex of TICAM-1 and an additional TLR4-binding adapter serves as the adapter [14].
  • Thus, a polyproline II interaction with the 3(10) helix likely facilitates NS3/4A recognition of TRIF, indicating a significant difference from NS3/4A recognition of viral substrates [15].
  • HCV evasion of double-stranded RNA signaling through Toll-like receptor 3 is mediated by the viral protease NS3/4A, which directs proteolysis of its proline-rich adaptor protein, Toll-IL-1 receptor domain containing adaptor-inducing interferon-beta (TRIF) [15].
  • These results imply that curcumin inhibits both MyD88- and TRIF-dependent pathways in LPS-induced TLR4 signaling [16].
  • To the Editor: role of MyD88 and Trif in acute allograft rejection: Glass half full or empty [17]?
 

Physical interactions of TICAM1

 

Regulatory relationships of TICAM1

  • Thus, the ability of TRIF to induce apoptosis was not dependent on its ability to activate either IFN regulatory factor-3 or NF-kappa B but was dependent on the presence of an intact RHIM [1].
  • Expression of SARM blocked gene induction 'downstream' of TRIF but not of MyD88 [6].
  • PIASy represses TRIF-induced ISRE and NF-kappaB activation but not apoptosis [20].
  • In addition, TRIF also induced apoptosis through a RIP/FADD/caspase-8-dependent and mitochondrion-independent pathway [7].
  • The cleaved N-terminal but not C-terminal fragment of TRAF1 was responsible for inhibiting TRIF signaling [21].
 

Other interactions of TICAM1

  • Zebrafish TICAM1 activates zebrafish IFN; however, it does so in an apparently IFN regulatory factor 3/7-independent manner [22].
  • As is the case in MyD88 and TIRAP, overexpression of TRIF activated the NF-kappaB-dependent promoter [23].
  • These findings suggest that TRIF is involved in the TLR signaling, particularly in the MyD88-independent pathway [23].
  • We named this TLR4-TICAM-1-bridging adapter TICAM-2 [14].
  • Here we characterize a fifth TIR adaptor, SARM, as a negative regulator of TRIF-dependent Toll-like receptor signaling [6].
 

Analytical, diagnostic and therapeutic context of TICAM1

  • Circular dichroism (CD) spectroscopy confirmed that a substantial fraction of TRIF exists as polyproline II helices, and inclusion of the polyproline track increased affinity of P side TRIF peptides for the HCV-BK protease [15].
  • After analysis of the nucleotide base sequences of a 1.2-kb fragment amplified from a dermatophyte fungus Trichophyton rubrum by arbitrarily primed PCR with random primer OPD18, a pair of primers (TRIF and TR1R) was designed and evaluated for specific identification of T. rubrum [24].

References

  1. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. Kaiser, W.J., Offermann, M.K. J. Immunol. (2005) [Pubmed]
  2. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Li, K., Foy, E., Ferreon, J.C., Nakamura, M., Ferreon, A.C., Ikeda, M., Ray, S.C., Gale, M., Lemon, S.M. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  3. Pathological role of Toll-like receptor signaling in cerebral malaria. Coban, C., Ishii, K.J., Uematsu, S., Arisue, N., Sato, S., Yamamoto, M., Kawai, T., Takeuchi, O., Hisaeda, H., Horii, T., Akira, S. Int. Immunol. (2007) [Pubmed]
  4. Recognition and signaling by toll-like receptors. West, A.P., Koblansky, A.A., Ghosh, S. Annu. Rev. Cell Dev. Biol. (2006) [Pubmed]
  5. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. An, H., Zhao, W., Hou, J., Zhang, Y., Xie, Y., Zheng, Y., Xu, H., Qian, C., Zhou, J., Yu, Y., Liu, S., Feng, G., Cao, X. Immunity (2006) [Pubmed]
  6. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Carty, M., Goodbody, R., Schröder, M., Stack, J., Moynagh, P.N., Bowie, A.G. Nat. Immunol. (2006) [Pubmed]
  7. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. Han, K.J., Su, X., Xu, L.G., Bin, L.H., Zhang, J., Shu, H.B. J. Biol. Chem. (2004) [Pubmed]
  8. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene. Hardy, M.P., McGGettrick, A.F., O'Neill, L.A. Biochem. J. (2004) [Pubmed]
  9. LPS, dsRNA and the interferon bridge to adaptive immune responses: Trif, Tram, and other TIR adaptor proteins. Hoebe, K., Beutler, B. J. Endotoxin Res. (2004) [Pubmed]
  10. A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. Macagno, A., Molteni, M., Rinaldi, A., Bertoni, F., Lanzavecchia, A., Rossetti, C., Sallusto, F. J. Exp. Med. (2006) [Pubmed]
  11. TRIF-GEFH1-RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation. Kamon, H., Kawabe, T., Kitamura, H., Lee, J., Kamimura, D., Kaisho, T., Akira, S., Iwamatsu, A., Koga, H., Murakami, M., Hirano, T. EMBO J. (2006) [Pubmed]
  12. Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation. Krasowska-Zoladek, A., Banaszewska, M., Kraszpulski, M., Konat, G.W. J. Neurosci. Res. (2007) [Pubmed]
  13. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway. Harari, O.A., Alcaide, P., Ahl, D., Luscinskas, F.W., Liao, J.K. Circ. Res. (2006) [Pubmed]
  14. TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons. Seya, T., Oshiumi, H., Sasai, M., Akazawa, T., Matsumoto, M. Int. J. Biochem. Cell Biol. (2005) [Pubmed]
  15. Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. Ferreon, J.C., Ferreon, A.C., Li, K., Lemon, S.M. J. Biol. Chem. (2005) [Pubmed]
  16. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Youn, H.S., Saitoh, S.I., Miyake, K., Hwang, D.H. Biochem. Pharmacol. (2006) [Pubmed]
  17. To the Editor: role of MyD88 and Trif in acute allograft rejection: Glass half full or empty? Goldstein, D. Eur. J. Immunol. (2006) [Pubmed]
  18. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. Wang, Y.Y., Li, L., Han, K.J., Zhai, Z., Shu, H.B. FEBS Lett. (2004) [Pubmed]
  19. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4. Aksoy, E., Vanden Berghe, W., Detienne, S., Amraoui, Z., Fitzgerald, K.A., Haegeman, G., Goldman, M., Willems, F. Eur. J. Immunol. (2005) [Pubmed]
  20. PIASy represses TRIF-induced ISRE and NF-kappaB activation but not apoptosis. Zhang, J., Xu, L.G., Han, K.J., Wei, X., Shu, H.B. FEBS Lett. (2004) [Pubmed]
  21. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling. Su, X., Li, S., Meng, M., Qian, W., Xie, W., Chen, D., Zhai, Z., Shu, H.B. Eur. J. Immunol. (2006) [Pubmed]
  22. Evidence for Evolving Toll-IL-1 Receptor-Containing Adaptor Molecule Function in Vertebrates. Sullivan, C., Postlethwait, J.H., Lage, C.R., Millard, P.J., Kim, C.H. J. Immunol. (2007) [Pubmed]
  23. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., Akira, S. J. Immunol. (2002) [Pubmed]
  24. PCR identification of dermatophyte fungi Trichophyton rubrum, T. soudanense and T. gourvilii. Liu, D., Pearce, L., Lilley, G., Coloe, S., Baird, R., Pedersen, J. J. Med. Microbiol. (2002) [Pubmed]
 
WikiGenes - Universities